Concepts (223)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aortic Valve | 13 | 2018 | 60 | 1.970 |
Why?
|
| Bioprosthesis | 10 | 2018 | 61 | 1.500 |
Why?
|
| Cardiac Surgical Procedures | 10 | 2021 | 81 | 1.310 |
Why?
|
| Heart Valve Prosthesis Implantation | 8 | 2018 | 50 | 1.220 |
Why?
|
| Heart Valve Prosthesis | 9 | 2018 | 60 | 1.150 |
Why?
|
| Cardiopulmonary Bypass | 9 | 2012 | 56 | 0.940 |
Why?
|
| Coronary Artery Bypass | 9 | 2013 | 111 | 0.930 |
Why?
|
| Pulmonary Artery | 3 | 2012 | 25 | 0.650 |
Why?
|
| Heart Valve Diseases | 6 | 2020 | 29 | 0.630 |
Why?
|
| Myocardial Ischemia | 4 | 2020 | 105 | 0.590 |
Why?
|
| Prosthesis Design | 6 | 2018 | 102 | 0.550 |
Why?
|
| Mitral Valve Insufficiency | 2 | 2011 | 32 | 0.540 |
Why?
|
| Coronary Disease | 3 | 2007 | 214 | 0.520 |
Why?
|
| Esophagus | 2 | 2015 | 25 | 0.520 |
Why?
|
| Chymases | 4 | 2020 | 8 | 0.520 |
Why?
|
| Aortic Valve Insufficiency | 7 | 2018 | 27 | 0.510 |
Why?
|
| Congenital Abnormalities | 1 | 2015 | 10 | 0.480 |
Why?
|
| Larynx | 1 | 2015 | 19 | 0.480 |
Why?
|
| Abnormalities, Multiple | 1 | 2015 | 28 | 0.470 |
Why?
|
| Trachea | 1 | 2015 | 52 | 0.460 |
Why?
|
| Postoperative Complications | 7 | 2013 | 828 | 0.450 |
Why?
|
| Coronary Vessel Anomalies | 2 | 2012 | 8 | 0.440 |
Why?
|
| Aortic Valve Stenosis | 5 | 2020 | 41 | 0.440 |
Why?
|
| Echocardiography, Transesophageal | 6 | 2012 | 58 | 0.420 |
Why?
|
| Aged | 27 | 2021 | 10538 | 0.420 |
Why?
|
| Extracellular Matrix | 1 | 2015 | 243 | 0.410 |
Why?
|
| Blood Loss, Surgical | 2 | 2011 | 54 | 0.410 |
Why?
|
| Cognition Disorders | 2 | 2007 | 370 | 0.410 |
Why?
|
| Humans | 45 | 2021 | 32798 | 0.400 |
Why?
|
| Female | 32 | 2020 | 20261 | 0.390 |
Why?
|
| Aortic Aneurysm | 2 | 2010 | 11 | 0.390 |
Why?
|
| Middle Aged | 25 | 2020 | 12125 | 0.380 |
Why?
|
| Antifibrinolytic Agents | 2 | 2013 | 16 | 0.380 |
Why?
|
| Male | 33 | 2020 | 19641 | 0.370 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 3 | 2017 | 136 | 0.370 |
Why?
|
| Embolism, Cholesterol | 1 | 2011 | 6 | 0.340 |
Why?
|
| Angiotensinogen | 4 | 2020 | 59 | 0.340 |
Why?
|
| Sinus of Valsalva | 1 | 2010 | 3 | 0.340 |
Why?
|
| Ventricular Function, Left | 2 | 2020 | 252 | 0.340 |
Why?
|
| Mitral Valve | 3 | 2011 | 39 | 0.330 |
Why?
|
| Aortic Aneurysm, Thoracic | 2 | 2015 | 11 | 0.330 |
Why?
|
| Coronary Artery Bypass, Off-Pump | 2 | 2007 | 6 | 0.310 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2011 | 532 | 0.300 |
Why?
|
| Follow-Up Studies | 10 | 2020 | 2284 | 0.300 |
Why?
|
| Angiotensin II | 3 | 2015 | 245 | 0.300 |
Why?
|
| Heart Diseases | 2 | 2010 | 116 | 0.290 |
Why?
|
| Aprotinin | 2 | 2005 | 4 | 0.290 |
Why?
|
| Aorta, Thoracic | 2 | 2006 | 85 | 0.290 |
Why?
|
| Treatment Outcome | 15 | 2018 | 3438 | 0.270 |
Why?
|
| Heart Valves | 2 | 2005 | 16 | 0.270 |
Why?
|
| Heart Atria | 2 | 2020 | 78 | 0.270 |
Why?
|
| Reoperation | 6 | 2011 | 260 | 0.260 |
Why?
|
| Aneurysm, Dissecting | 2 | 2004 | 12 | 0.260 |
Why?
|
| Risk Factors | 9 | 2018 | 3974 | 0.240 |
Why?
|
| Adult | 16 | 2020 | 9560 | 0.240 |
Why?
|
| Peptide Fragments | 2 | 2020 | 403 | 0.240 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2005 | 6 | 0.240 |
Why?
|
| Echocardiography | 4 | 2020 | 182 | 0.220 |
Why?
|
| Time Factors | 7 | 2018 | 2183 | 0.220 |
Why?
|
| Retrospective Studies | 8 | 2018 | 3701 | 0.220 |
Why?
|
| Aneurysm, False | 2 | 2015 | 14 | 0.200 |
Why?
|
| Aged, 80 and over | 7 | 2018 | 4032 | 0.200 |
Why?
|
| Equipment Failure Analysis | 1 | 2002 | 42 | 0.190 |
Why?
|
| Atrial Fibrillation | 3 | 2020 | 391 | 0.190 |
Why?
|
| Vascular Surgical Procedures | 2 | 2017 | 92 | 0.180 |
Why?
|
| Infant, Newborn | 2 | 2015 | 694 | 0.170 |
Why?
|
| Atrial Appendage | 1 | 2021 | 24 | 0.170 |
Why?
|
| Postoperative Hemorrhage | 3 | 2013 | 42 | 0.170 |
Why?
|
| Cardiac-Gated Imaging Techniques | 2 | 2012 | 18 | 0.160 |
Why?
|
| Endocarditis | 2 | 2012 | 18 | 0.160 |
Why?
|
| Infant | 2 | 2015 | 1083 | 0.160 |
Why?
|
| Atherosclerosis | 1 | 2006 | 788 | 0.160 |
Why?
|
| Blood Vessel Prosthesis Implantation | 3 | 2012 | 68 | 0.160 |
Why?
|
| Prosthesis Failure | 2 | 2018 | 51 | 0.160 |
Why?
|
| Severity of Illness Index | 5 | 2020 | 881 | 0.150 |
Why?
|
| Animals | 9 | 2020 | 7569 | 0.150 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2012 | 947 | 0.150 |
Why?
|
| Stents | 2 | 2018 | 174 | 0.150 |
Why?
|
| Hypertension | 2 | 2017 | 976 | 0.140 |
Why?
|
| Catheterization, Peripheral | 1 | 2017 | 30 | 0.130 |
Why?
|
| Femoral Artery | 1 | 2017 | 50 | 0.130 |
Why?
|
| Aorta | 2 | 2011 | 127 | 0.130 |
Why?
|
| Swine | 3 | 2009 | 216 | 0.130 |
Why?
|
| Tracheotomy | 1 | 2015 | 1 | 0.120 |
Why?
|
| Renin-Angiotensin System | 1 | 2017 | 178 | 0.120 |
Why?
|
| Hemodynamics | 4 | 2018 | 162 | 0.110 |
Why?
|
| Stroke | 1 | 2020 | 609 | 0.110 |
Why?
|
| Hospital Mortality | 3 | 2006 | 205 | 0.110 |
Why?
|
| Factor IX | 1 | 2013 | 11 | 0.100 |
Why?
|
| Angiotensin I | 1 | 2015 | 241 | 0.100 |
Why?
|
| Age Factors | 2 | 2007 | 1197 | 0.100 |
Why?
|
| Preoperative Care | 3 | 2012 | 122 | 0.100 |
Why?
|
| Prognosis | 4 | 2020 | 1544 | 0.100 |
Why?
|
| Length of Stay | 3 | 2017 | 329 | 0.100 |
Why?
|
| Mitral Valve Stenosis | 1 | 2012 | 10 | 0.100 |
Why?
|
| Echocardiography, Doppler | 2 | 2010 | 45 | 0.090 |
Why?
|
| Probability | 3 | 2007 | 157 | 0.090 |
Why?
|
| Coronary Angiography | 1 | 2012 | 162 | 0.090 |
Why?
|
| Dexmedetomidine | 1 | 2011 | 8 | 0.090 |
Why?
|
| Hypnotics and Sedatives | 1 | 2011 | 29 | 0.090 |
Why?
|
| Propofol | 1 | 2011 | 20 | 0.090 |
Why?
|
| Heart Aneurysm | 1 | 2011 | 3 | 0.090 |
Why?
|
| Survival Rate | 3 | 2010 | 894 | 0.080 |
Why?
|
| Transplantation, Homologous | 1 | 2010 | 151 | 0.080 |
Why?
|
| Heart Failure | 1 | 2017 | 695 | 0.080 |
Why?
|
| Cerebrovascular Circulation | 1 | 2011 | 95 | 0.080 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2010 | 12 | 0.080 |
Why?
|
| Bioreactors | 1 | 2009 | 61 | 0.070 |
Why?
|
| Constriction | 2 | 2005 | 13 | 0.070 |
Why?
|
| Intraoperative Care | 2 | 2012 | 48 | 0.070 |
Why?
|
| Ticlopidine | 1 | 2008 | 17 | 0.070 |
Why?
|
| Premedication | 1 | 2008 | 16 | 0.070 |
Why?
|
| Ventricular Remodeling | 2 | 2020 | 64 | 0.070 |
Why?
|
| Surgical Instruments | 1 | 2007 | 25 | 0.070 |
Why?
|
| Survival Analysis | 3 | 2020 | 486 | 0.070 |
Why?
|
| Endothelial Cells | 1 | 2009 | 197 | 0.070 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2008 | 85 | 0.070 |
Why?
|
| Child, Preschool | 1 | 2011 | 1282 | 0.070 |
Why?
|
| Saphenous Vein | 1 | 2007 | 20 | 0.070 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2007 | 12 | 0.060 |
Why?
|
| Sex Distribution | 1 | 2007 | 185 | 0.060 |
Why?
|
| Postoperative Care | 1 | 2007 | 78 | 0.060 |
Why?
|
| Neuropsychological Tests | 1 | 2007 | 363 | 0.060 |
Why?
|
| RNA, Messenger | 2 | 2020 | 498 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2008 | 2327 | 0.060 |
Why?
|
| Logistic Models | 2 | 2005 | 783 | 0.060 |
Why?
|
| Postoperative Period | 1 | 2006 | 99 | 0.060 |
Why?
|
| Hematocrit | 1 | 2005 | 23 | 0.060 |
Why?
|
| Causality | 1 | 2005 | 39 | 0.060 |
Why?
|
| Drug Interactions | 1 | 2005 | 78 | 0.060 |
Why?
|
| Nervous System Diseases | 1 | 2005 | 41 | 0.060 |
Why?
|
| Hyperglycemia | 1 | 2005 | 81 | 0.060 |
Why?
|
| North Carolina | 2 | 2010 | 1546 | 0.060 |
Why?
|
| Heart Rate | 1 | 2007 | 343 | 0.060 |
Why?
|
| Drug Therapy, Combination | 1 | 2005 | 289 | 0.060 |
Why?
|
| Mental Disorders | 1 | 2005 | 125 | 0.050 |
Why?
|
| Cattle | 1 | 2004 | 108 | 0.050 |
Why?
|
| Insulin | 2 | 2005 | 367 | 0.050 |
Why?
|
| Polyethylene Terephthalates | 1 | 2004 | 3 | 0.050 |
Why?
|
| Pericardium | 1 | 2004 | 55 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2005 | 682 | 0.050 |
Why?
|
| Comorbidity | 1 | 2005 | 573 | 0.050 |
Why?
|
| Body Mass Index | 1 | 2007 | 908 | 0.050 |
Why?
|
| Suture Techniques | 1 | 2004 | 61 | 0.050 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2003 | 6 | 0.050 |
Why?
|
| Tissue Engineering | 1 | 2009 | 659 | 0.050 |
Why?
|
| Enoxaparin | 1 | 2003 | 21 | 0.050 |
Why?
|
| Hemoglobins | 1 | 2003 | 49 | 0.050 |
Why?
|
| Heart Arrest, Induced | 1 | 2003 | 3 | 0.050 |
Why?
|
| Hemostatics | 1 | 2003 | 11 | 0.050 |
Why?
|
| Hypothermia, Induced | 1 | 2003 | 16 | 0.050 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2004 | 168 | 0.050 |
Why?
|
| Blood Transfusion | 1 | 2003 | 76 | 0.050 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2002 | 16 | 0.050 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2003 | 87 | 0.050 |
Why?
|
| Risk Assessment | 4 | 2012 | 1460 | 0.050 |
Why?
|
| Pre-Eclampsia | 1 | 2003 | 66 | 0.050 |
Why?
|
| Cardiotonic Agents | 1 | 2002 | 43 | 0.050 |
Why?
|
| Incidence | 1 | 2005 | 1238 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2005 | 422 | 0.050 |
Why?
|
| Cesarean Section | 1 | 2003 | 113 | 0.050 |
Why?
|
| Cause of Death | 1 | 2002 | 240 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2002 | 180 | 0.040 |
Why?
|
| Angiotensins | 1 | 2021 | 42 | 0.040 |
Why?
|
| Stroke Volume | 2 | 2020 | 370 | 0.040 |
Why?
|
| Cohort Studies | 3 | 2013 | 1844 | 0.040 |
Why?
|
| Heart Ventricles | 1 | 2020 | 146 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 316 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2020 | 497 | 0.040 |
Why?
|
| Academic Medical Centers | 2 | 2011 | 162 | 0.040 |
Why?
|
| Punctures | 1 | 2017 | 36 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2018 | 203 | 0.030 |
Why?
|
| Receptors, Angiotensin | 1 | 2017 | 61 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2017 | 369 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2017 | 204 | 0.030 |
Why?
|
| Child | 1 | 2002 | 2478 | 0.030 |
Why?
|
| Drug Administration Schedule | 2 | 2008 | 271 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2015 | 80 | 0.030 |
Why?
|
| Aging | 1 | 2021 | 938 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2015 | 191 | 0.030 |
Why?
|
| Adolescent | 1 | 2002 | 3638 | 0.030 |
Why?
|
| Rodentia | 1 | 2014 | 10 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2014 | 81 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 282 | 0.030 |
Why?
|
| Chest Tubes | 1 | 2013 | 5 | 0.030 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2013 | 4 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 352 | 0.030 |
Why?
|
| Blood Coagulation Disorders | 1 | 2013 | 13 | 0.030 |
Why?
|
| Heart | 1 | 2014 | 185 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 247 | 0.020 |
Why?
|
| Sternotomy | 1 | 2012 | 4 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2012 | 21 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2012 | 57 | 0.020 |
Why?
|
| Radiography | 2 | 2004 | 386 | 0.020 |
Why?
|
| Angiography | 1 | 2012 | 80 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 563 | 0.020 |
Why?
|
| Critical Care | 1 | 2011 | 108 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2011 | 876 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2009 | 96 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2011 | 252 | 0.020 |
Why?
|
| Sheep | 1 | 2009 | 233 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 576 | 0.020 |
Why?
|
| Blood Volume | 1 | 2008 | 9 | 0.020 |
Why?
|
| Platelet Transfusion | 1 | 2008 | 16 | 0.020 |
Why?
|
| Rupture, Spontaneous | 1 | 2007 | 20 | 0.020 |
Why?
|
| Radiographic Image Enhancement | 1 | 2007 | 27 | 0.020 |
Why?
|
| Erythrocyte Transfusion | 1 | 2008 | 36 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 767 | 0.020 |
Why?
|
| Prevalence | 1 | 2010 | 1002 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2005 | 156 | 0.010 |
Why?
|
| History, 17th Century | 1 | 2004 | 3 | 0.010 |
Why?
|
| Heart Function Tests | 1 | 2004 | 8 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2005 | 525 | 0.010 |
Why?
|
| Anesthesia, General | 1 | 2004 | 33 | 0.010 |
Why?
|
| Paraplegia | 1 | 2003 | 7 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2003 | 97 | 0.010 |
Why?
|
| Heparin | 1 | 2003 | 70 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 526 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 622 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2004 | 413 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2004 | 483 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2002 | 494 | 0.010 |
Why?
|
| Pregnancy | 1 | 2003 | 981 | 0.010 |
Why?
|